Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients

James P. Corsetti, Dan Ryan, Arthur J. Moss, David L. Rainwater, Wojciech Zareba, Charles E. Sparks

    Research output: Contribution to journalArticlepeer-review

    13 Scopus citations

    Fingerprint Dive into the research topics of 'Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences